List of Diagnostics Companies in Hungary - 3

Avidin Ltd. was established in 2002. Avidin has started its drug discovery programme in 2007 in the field of cancer and infectious diseases. The company in-licensed an anti-cancer compound family interfering lipid vesicle formation and trafficking, a novel way to combat this disease. The company is developing novel approaches for high throughput gene expression analysis and screening technologies for drug discovery. Avidin has started focusing on chemical library synthesis in 2007 for patentable bioactive compounds. Avidin is the local distributor of several products related to different molecular biological methods: BioTrove (Woburn, MA, USA), Bioneer (Daeleon, Korea).

Mediso is one of the World's largest suppliers of various medical diagnostic and research purpose, single and multimodality imaging devices. The company was founded in 1990 by experts in the largest research and manufacturing company in Europe which has been engaged of nuclear equipment development and production since 1960. Currently Mediso offers 4 imaging modalities - SPECT, PET, CT, MRI - for professionals working in laboratories and nuclear medicine departments. Mediso products are sold worldwide directly and through a network of distributors. There are more than 1650 imaging systems operating in more than 100 countries around the world.

Omixon is a global transplantation diagnostic company with a mission to provide histocompatibility laboratories with innovative technologies to improve transplant outcomes. Omixon is headquartered in Budapest, Hungary, with operations in the United States, Brazil and the Netherlands serving more than 100 laboratories worldwide. Building on multidisciplinary competences in bioinformatics, software engineering, molecular biology and regulatory science, Omixon transforms molecular biology innovations into state-of-the-art products in transplant diagnostics. Omixon was the first to successfully introduce NGS-based HLA typing kit and software in 2014 by bringing Holotype HLA, an NGS-based HLA genotyping product, and HLA Twin software to market. Omixon Twin delivers the most accurate high-resolution HLA genotyping and is used in more than 100+ laboratories worldwide. Omixon was the first to release a high-resolution HLA genotyping product NanoTYPE HLA™ with less than 5 hours turnaround time on the Oxford Nanopore sequencing platform complemented by NanoTYPER™ analysis software. Omixon is the first to bring to market the first donor-derived cell-free DNA kit HoloGRAFT for laboratories with donor-informative genetic markers with primer and probe sequences that are absent in the patient genotype by design. On October 16, 2024, in Barcelona, Spain, Werfen announced the completion of its acquisition of Omixon, after securing all required regulatory and antitrust approvals.